Home backup

Liquid Biopsy - its time has come
Prognostic
Highly powered capability to give important information about disease progression or response to proposed therapy, powered to predict the future
Better patient experience/outcomes

Better information means better treatment for high-risk patients & less monitoring (and peace of mind) for low-risk patients

Multiple Myeloma

Key directions for pathologists/clinicians in treatment regimen

Better Tests, Better Treatments & Better Outcomes

Telo Genomics is a precision medicine company with a proprietary software platform designed to predict the course of certain diseases and to tailor treatment options for the individual patient.

Unlike other diagnostic companies, our platform goes beyond sequencing mutations in the DNA, to measure the stability of the entire genome.

High Predictive Power Prognostics

highly powered capability to give important information about disease progression or response to proposed therapy, powered to predict the future

Better patient & healthcare providers experience

better information lands to better treatment for high-risk patients while avoiding overtreatment an unnecessary monitoring of low risk patients thus improving patients quality of life

Focused on unmet market needs

specific useful applications with direct path to the clinic recognizing the current clinical paradigm and integrates into the current clinical workflow

JOIN OUR TEAM

Although we are not actively hiring, we are always inviting the best and the brightest professionals who are dedicated to innovation to contact us.

BOARD AND MANAGEMENT

Our Team

Contact Us

info@telodx.com

Ph : 416-673-8487

Address

MaRS Centre, South Tower
101 College Street, Suite 200
Toronto, Ontario
Canada M5G 1L7

Contact Us

info@telodx.com
Ph : 416-673-8487

Address

MaRS Centre, South Tower
101 College Street, Suite 200
Toronto, Ontario
Canada M5G 1L7

(c) 2020 Telo Genomics . All rights reserved.

Website Designed & Maintained By :: WebStudio.ca